The TRANSFORM-2 study found patients receiving Spravato were 70% more likely to achieve remission than those receiving a newly initiated oral antidepressant plus placebo
Spravato Treatment in Southside Place, TX: FDA-Approved Relief for Treatment-Resistant Depression
Find the best Spravato treatment clinic serving Southside Place, TX at Catalyst Health & Wellness — a REMS-certified Houston provider of the only FDA-approved nasal spray for treatment-resistant depression. Led by Dr. Ho, board-certified anesthesiologist and former pediatrician. Our South Loop location is minutes from Southside Place. Open Monday–Sunday, 5am–9pm.
Rebuild with Spravato Treatment Southside Place
Southside Place is one of the most distinctive communities in all of Houston — a fully incorporated city of barely two hundred acres, completely surrounded by larger neighbors yet fiercely independent, one of the 13th wealthiest locations in Texas by per capita income, and home to families who have chosen it precisely because it offers something most communities can’t: genuine intimacy at the center of a major metropolitan area. Residents here are, almost by definition, people who know the difference between what merely looks good and what actually is good.
That same discernment belongs in mental health care. When treatment-resistant depression has been your reality — when two or more antidepressants have run their course without delivering the relief you needed — what you don’t need is another treatment that looks like the answer but uses the same mechanism as everything that has already failed. At Catalyst Health & Wellness, we serve Southside Place residents — and patients from West University Place, Bellaire, Upper Kirby, and the medical center corridor — as a fully REMS-certified Spravato provider, with our South Loop location just minutes away. Spravato (esketamine) is the only FDA-approved nasal spray developed for treatment-resistant depression, and it works through a neurological mechanism that every prior antidepressant has bypassed. The Mayo Clinic lists it as a nasal spray treatment administered in a healthcare setting for patients “whose symptoms do not improve after trying at least two antidepressants.” With Dr. Ho’s clinical expertise, attentive care, and flexible hours, that treatment is immediately accessible to Southside Place patients ready for it.
What is Spravato Therapy?
Spravato (esketamine) earned FDA breakthrough therapy designation before receiving full approval in 2019 — the first genuinely new antidepressant mechanism in over three decades of psychiatry. The FDA extended that approval in 2020 to adults with major depressive disorder experiencing active suicidal ideation or behaviors. In January 2025, the FDA approved Spravato as a standalone monotherapy for TRD — the first medication ever cleared for use without a simultaneously prescribed oral antidepressant in treatment-resistant depression, for adults who have had inadequate responses to at least two prior medications.
Research consistently shows powerful results:
What Our Patients Say
Take the First Step Toward Healing
Book Appointment
Conditions We Treat with Spravato Therapy in Southside Place
Spravato holds FDA approval for two specific, well-established clinical indications — every qualifying Southside Place patient receives a treatment with a rigorously documented evidence base. At Catalyst Health & Wellness, we offer Spravato for:
Your Spravato Therapy Journey at Catalyst Health & Wellness
Every step of the Spravato process at Catalyst has been designed to minimize barriers and maximize clarity for patients managing demanding lives. Here's what to expect from first call through long-term care.
Step 1: Free Phone Consultation
Your first call costs nothing. A clinical team member will discuss your depression history, medication background, and what your daily life looks like now. You’ll receive an honest picture of whether Spravato makes sense for your situation — and a direct answer if it doesn’t.
Step 2: Insurance Verification & Prior Authorization
Spravato is often covered by insurance for qualifying patients, but prior authorization is nearly always required. Our team handles that process entirely: verifying benefits, preparing documentation, submitting the prior auth, and following up until approval is secured. You make the clinical decision; we manage the administrative process.
Step 3: Before Your First Visit
Before your appointment, we’ll walk through everything you need to know: dietary guidelines, what to bring, how to arrange transportation, and any timing notes for current medications. Your first session will have no surprises.
Step 4: Day of Treatment
Plan for approximately two to two-and-a-half hours per visit. You’ll need a designated driver or pre-arranged rideshare — driving on treatment days isn’t permitted. Come comfortable and ready to rest. That’s the complete scope of preparation.
Step 5: Your Treatment Session
You’ll settle into a private, purpose-designed treatment room — reclinable chair, soft adjustable lighting, warm blankets, noise-cancelling headphones available. Spravato is self-administered as a nasal spray under Dr. Ho’s team’s direct clinical supervision. Vital signs, blood pressure, and overall response are monitored throughout. Temporary effects — mild dissociation, light-headedness — are expected and typically resolve within the two-hour monitoring window.
Step 6: Recovery & Aftercare
After monitoring concludes, you’ll leave with your driver. Driving should wait until the morning after a full night’s sleep. Our team follows up between sessions to track your response and address anything before your next appointment.
Step 7: Treatment Schedule & Maintenance
The protocol begins with twice-weekly sessions during weeks one through four, steps to once weekly in weeks five through eight, then transitions to individualized maintenance — weekly, every two weeks, or monthly — based on how you’re actually responding. Your response guides the timeline.
The Science Behind Spravato for Treatment-Resistant Depression
Spravato’s FDA approval rests on a comprehensive evidence base: two pivotal phase 3 randomized controlled trials, a 2025 monotherapy approval study, and nearly six years of post-approval real-world data reviewed by regulatory agencies in over 77 countries.
The TRANSFORM-2 study, published in the American Journal of Psychiatry, enrolled patients with confirmed treatment-resistant depression in a double-blind comparison of flexibly-dosed Spravato plus a newly initiated oral antidepressant versus antidepressant plus placebo. Patients receiving Spravato were 70% more likely to achieve remission. Statistically significant improvement was measurable within 24 hours of the first dose — a result that reflects the glutamate-driven neuroplasticity cascade Spravato initiates in the prefrontal cortex, well before any monoamine-based effect could have accumulated. The Mayo Clinic specifically cites esketamine’s speed as among its most important clinical characteristics, noting it acts “rapidly, typically within a couple of hours.”
The SUSTAIN-1 trial, published in JAMA Psychiatry, confirmed durability. Patients who achieved stable remission or response were randomized to continue Spravato or transition to placebo. Those who continued showed significantly longer time to relapse — a hazard ratio of 0.49 (p=0.003) — confirming that maintenance treatment is not a formality but a meaningful protection against the return of symptoms.
Key research findings:
- Spravato initiates synaptogenesis and neuroplasticity in mood-regulating brain regions within hours of the first dose — structural neural repair that monoamine-targeting antidepressants don’t produce on any timeline
- The ASPIRE I and II trials confirmed statistically significant depressive symptom reduction within 24 hours in patients with MDD and active suicidal ideation — the first FDA-approved rapid pharmacological option for that clinical population
- Early academic studies showed single doses of intravenous ketamine produced rapid antidepressant effects in TRD patients with short-term response rates between 60 and 70 percent, establishing the mechanistic foundation that led to esketamine’s approval
- The January 2025 FDA monotherapy approval means Spravato can now serve as the sole treatment in a qualifying patient’s regimen — a new pathway that doesn’t require an existing oral antidepressant
Why Choose Catalyst Health & Wellness for Spravato Treatment in Southside Place
01
REMS-Certified Provider
The FDA requires all Spravato treatments to occur in a certified healthcare setting under its REMS program. Catalyst Health & Wellness holds full REMS certification across all three Houston locations — including the South Loop location minutes from Southside Place. Every session meets every federal safety standard. For a community that values things close to home, the access is exceptional.
02
Led by Dr. Ho – Expert Medical Care
Dr. Ho’s credentials are precisely what Spravato treatment requires. His board certification in anesthesiology means deep expertise in esketamine pharmacology, clinical dosing, and the physician-level monitoring that administering an NMDA receptor antagonist demands. His background as a former pediatrician defines the culture of the entire clinic — patient-centered, attentive, and genuinely focused on how treatment feels from your perspective. Southside Place residents who hold every provider to a high standard will find that standard consistently met.
03
Insurance Navigation Support
Spravato stands apart from most innovative mental health treatments because major commercial insurance plans and Medicare frequently cover it for qualifying patients. Prior authorization is nearly always required, and managing that process on top of depression is a burden patients shouldn’t carry. Our team handles it entirely: benefit verification, prior auth submission, insurer follow-up, and appeals when needed. Your energy belongs to healing.
04
Whole-Person Approach
From the first call, we engage with you as a complete person — your full treatment history, your current circumstances, your goals, and what you want back. Treatment plans are built around that picture and updated as your response evolves. What this means for you:
- Plans personalized to your specific history and present situation
- Ongoing adjustments based on real response data, not a standard protocol
- Coordination with your existing psychiatrist or prescribing physician
- Long-term engagement that extends well beyond the initial induction series
05
Extended Hours & Flexible Scheduling
Each Spravato session requires two or more hours in clinic. Southside Place’s location — between Bellaire and the Texas Medical Center, within the 610 loop — means Catalyst’s South Loop location is effectively in the neighborhood. Add our 5am to 9pm hours, seven days a week, and scheduling treatment becomes genuinely simple. Pre-dawn appointments, evening sessions, weekend visits — all available without a significant commute.
06
Comprehensive Treatment Options
Spravato is a powerful tool, but it’s not the only one. When your clinical picture benefits from a multi-modal approach, Catalyst offers complementary evidence-based treatments under the same roof:
Ketamine Therapy
Broader applications including anxiety, PTSD, chronic pain, OCD, and bipolar depression
TMS Therapy
Non-invasive magnetic brain stimulation for depression and OCD
Stellate Ganglion Block
Targeted nerve block treatment for PTSD and anxiety
Our goal is to find the right combination of treatments for your unique situation — not to fit you into a one-size-fits-all protocol.
07
Safe, Comfortable Environment
Our treatment rooms were designed specifically for the Spravato experience — not repurposed from other clinical uses. Each is private, quiet, and carefully arranged: reclinable chairs, soft adjustable lighting, warm blankets, noise-cancelling headphones. Dr. Ho’s clinical team is present and monitoring throughout every session. You’re observed, supported, and never alone.
Getting Started with Spravato Treatment in Southside Place
For a community built on independence and discernment, the right mental health treatment deserves the same standards you’d apply to any other important decision. Spravato is FDA-approved, globally validated, backed by over a decade of research, and available at a clinic that’s minutes from Southside Place. If treatment-resistant depression has been the one area where the best available options haven’t delivered, this is the call to make.
Call us at 800-772-1242 for your free, no-obligation phone consultation. We’ll discuss your history honestly, answer every question, and give you a clear picture of whether Spravato is right for your situation. No charge, no pressure, complete confidentiality.
Our South Loop location — just minutes away — serves Southside Place patients with 5am to 9pm hours, seven days a week. Dr. Ho and the entire Catalyst team are ready when you are.
Monday-Sunday, 6am-9pm
Free consultation
Insurance assistance
Three Houston locations
REMS-certified provider
Commonly Asked Questions
Get Help NowHow quickly does Spravato therapy work?
Many patients notice improvements within hours or days of their first treatment. The TRANSFORM-2 study showed significant improvement compared to placebo within 24 hours. This rapid action is one of Spravato’s most remarkable qualities, especially compared to traditional antidepressants that can take 4 to 8 weeks to work.
Is Spravato therapy safe?
Yes, when administered by trained medical professionals in a REMS-certified setting. Spravato underwent extensive clinical trials before FDA approval. Common side effects like dissociation, dizziness, and temporary blood pressure increases typically resolve within 1-2 hours. We monitor your vital signs throughout treatment to ensure your safety.
How many treatments will I need?
During the first month, you’ll receive Spravato twice weekly. In the second month, treatment typically decreases to once weekly. After that, most patients continue with maintenance treatments once weekly or every two weeks. The exact frequency depends on your individual response. We’ll work with you to find the schedule that keeps you feeling your best.
What does Spravato treatment feel like?
Experiences vary from person to person. Many patients describe feeling relaxed, calm, or somewhat disconnected from their surroundings. Some people experience mild visual or sensory changes. These effects are temporary and typically resolve within 1-2 hours after treatment ends. Most patients find the experience manageable and therapeutic.
Can I drive after a Spravato treatment?
No, you cannot drive yourself home after Spravato treatment, and you should not drive until the next day after a restful night’s sleep. You’ll need to arrange transportation both to and from your appointment. By the time you leave our facility after the 2-hour observation period, you’ll feel much clearer, but driving remains unsafe until the following day.
Will my insurance cover Spravato?
Many insurance plans cover Spravato for qualifying patients since it’s FDA-approved for treatment-resistant depression. Coverage varies by plan and typically requires prior authorization. Our team handles the insurance process for you, including benefits verification and prior authorization submissions.
Can I continue my current medications?
Spravato is always used alongside an oral antidepressant, so you’ll continue taking your prescribed antidepressant medication. We’ll coordinate with your prescribing physician to ensure your overall treatment plan is optimized. Some medications may require adjustment before starting Spravato, which we’ll discuss during your consultation.
Do I need a referral from my doctor?
No, you don’t need a referral to begin Spravato therapy at Catalyst Health & Wellness. However, coordination with your current prescribing physician is important since Spravato must be used alongside an oral antidepressant. We encourage communication between all members of your healthcare team.
Our Locations
Blog & insight
Insights on Healing, Growth, and Mental Wellness
June 13, 2026
FAQ: Common Questions About Ketamine Treatment Answered
If you've been researching ketamine therapy in Houston, chances are you've come across a lot of conflicting information. One article calls it a miracle cure. Another paints it as a risky party drug. Somewhere in between sits the truth, and you deserve straightforward answers before making any decision about your mental health or chronic pain…
June 10, 2026
Can Ketamine Therapy Help with Both Depression and Anxiety?
If you've spent years battling depression only to find anxiety creeping in alongside it (or vice versa), you're not imagining the connection. These two conditions show up together far more often than people realize, and the overlap can make recovery feel like trying to untangle a knot that keeps tightening. Traditional antidepressants and anti-anxiety medications…
June 7, 2026
Neuropathic Pain and Ketamine: Relief When Nerve Pain Won’t Quit
If you live with neuropathic pain, you already know it doesn't behave like ordinary pain. It burns when nothing touched you. It shocks down your leg while you're sitting still. It turns the brush of a bedsheet into something sharp. And the medications your doctor prescribed, the gabapentin, the duloxetine, maybe even opioids, take the…
Make an Appointment
Our mission is to empower individuals to overcome life’s challenges through professional psychological support.